BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6137221)

  • 1. Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1983 Aug; 32(16):2411-6. PubMed ID: 6137221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of carbidine on dopamine turnover in the rat corpus striatum].
    Malikova LA; Arefolov VA
    Farmakol Toksikol; 1980; 43(3):310-3. PubMed ID: 6108865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slices.
    Kerwin RW; Rupniak NM; Jenner P; Marsden CD
    Neuroscience; 1984 Jan; 11(1):205-10. PubMed ID: 6143281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
    Parsons B; Togasaki DM; Kassir S; Przedborski S
    J Neurochem; 1995 Nov; 65(5):2057-64. PubMed ID: 7595490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR; Budygin EA; Kovalev GI; Kudrin VS; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(7):47-9. PubMed ID: 1358258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an inhibitory presynaptic component of neuroleptic drug action.
    de Belleroche JS; Bradford HF
    Br J Pharmacol; 1981 Mar; 72(3):427-33. PubMed ID: 6114766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.
    Stamford JA; Kruk ZL; Millar J
    Br J Pharmacol; 1988 Jul; 94(3):924-32. PubMed ID: 2902896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.
    Turowski B; Szkrybalo M; Anderson K; Miller D; Uretsky N
    Biochem Pharmacol; 1984 Aug; 33(15):2371-6. PubMed ID: 6466358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S; Briley MS; Dubocovich ML; Langer SZ
    Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of some neuroleptics and d-amphetamine on striatal 2-phenylethylamine in the mouse.
    Juorio AV; Greenshaw AJ; Zhu MY; Paterson IA
    Gen Pharmacol; 1991; 22(2):407-13. PubMed ID: 1676007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuroleptics on dopamine release from striatal slices.
    Yamada S; Kojima H; Tsutsumi T; Yokoo H; Takamuki K; Anraku S; Nishi S; Inanaga K
    Kurume Med J; 1985; 32(2):127-30. PubMed ID: 3831593
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life.
    Velley L; Blanc G; Tassin JP; Thierry AM; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):97-102. PubMed ID: 240129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoamine antagonism in relation to the direct effect of neuroleptics on the release of stimulating amino acid neuromediators].
    Kovalev GI; Prikhozhan AV; Raevskiĭ KS
    Farmakol Toksikol; 1990; 53(5):22-4. PubMed ID: 1979280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclindole and flucindole: novel tetrahydrocarbazolamine neuroleptics.
    Wood PL; McQuade PS
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):773-7. PubMed ID: 6152347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
    Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV
    Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.